193 related articles for article (PubMed ID: 16230887)
1. Angiotensin receptor blockers in congestive heart failure: evidence, concerns, and controversies.
Bhatia V; Bhatia R; Mathew B
Cardiol Rev; 2005; 13(6):297-303. PubMed ID: 16230887
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
3. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of Sadko-CHF study)].
Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
Ter Arkh; 2006; 78(8):14-20. PubMed ID: 17078211
[TBL] [Abstract][Full Text] [Related]
4. [Is triple combination of different neurohormonal modulators recommended for treatment of mild-to-moderate congestive heart failure patients? (Results of SADKO-CHF study). Part 2].
Skvortsov AA; Mareev VIu; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Masenko VP; Belenkov IuN
Ter Arkh; 2006; 78(9):61-71. PubMed ID: 17076227
[TBL] [Abstract][Full Text] [Related]
5. [Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure].
Kuwabara Y; Komuro I
Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):255-61. PubMed ID: 15768589
[No Abstract] [Full Text] [Related]
6. Angiotensin receptor blockers and aldosterone antagonists in chronic heart failure.
Miller AB; Srivastava P
Cardiol Clin; 2001 May; 19(2):195-202, v. PubMed ID: 11407105
[TBL] [Abstract][Full Text] [Related]
7. Valsartan for the treatment of heart failure.
Latini R; Masson S; Staszewsky L; Maggioni AP
Expert Opin Pharmacother; 2004 Jan; 5(1):181-93. PubMed ID: 14680446
[TBL] [Abstract][Full Text] [Related]
8. A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure.
Erhardt LR
Int J Clin Pract; 2005 May; 59(5):571-8. PubMed ID: 15857354
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of heart failure based on large-scale clinical trials: renin-angiotensin system antagonists and beta-blockers].
Kubota T; Takeshita A
Nihon Rinsho; 2003 May; 61(5):801-6. PubMed ID: 12755006
[TBL] [Abstract][Full Text] [Related]
10. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
McMurray J; Cohen-Solal A; Dietz R; Eichhorn E; Erhardt L; Hobbs FD; Krum H; Maggioni A; McKelvie RS; Piña IL; Soler-Soler J; Swedberg K
Eur J Heart Fail; 2005 Aug; 7(5):710-21. PubMed ID: 16087129
[TBL] [Abstract][Full Text] [Related]
11. Rationale for the use of combination angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker therapy in heart failure.
Yasumura Y; Miyatake K; Okamoto H; Miyauchi T; Kawana M; Tsutamoto T; Kitakaze M; Matsubara H; Takaoka H; Anzai T; Himeno H; Yokoyama H; Yokoya K; Shintani U; Hashimoto K; Koretsune Y; Nakamura Y; Imai K; Maruyama S; Masaoka Y; Sekiya M; Shiraki T; Shinohara H; Ozono K; Matsuoka T; Miyao Y; Nomura F
Circ J; 2004 Apr; 68(4):361-6. PubMed ID: 15056835
[TBL] [Abstract][Full Text] [Related]
12. [Angiotensin I receptor blockers for heart failure].
Fruhwald FM; Kickenweiz E; Zweiker R; Klein W
Wien Med Wochenschr; 2001; 151(7-8):157-9. PubMed ID: 11450163
[TBL] [Abstract][Full Text] [Related]
13. [Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect of monotherapy (data from the trial SADKO-CHF)].
Skvortsov AA; Nasonova SN; Sychev AV; Arbolishvili GN; Baklanova NA; Mareev VIu; Belenkov IuN
Ter Arkh; 2005; 77(8):34-43. PubMed ID: 16206603
[TBL] [Abstract][Full Text] [Related]
14. [Review of randomized trials of angiotensin receptor blockers in the treatment of patients with congestive heart failure].
Rakugi H; Ogihara T
Nihon Rinsho; 2001 Oct; 59(10):2051-61. PubMed ID: 11676153
[TBL] [Abstract][Full Text] [Related]
15. Lack of deleterious interaction between angiotensin receptor blockers and beta-blockers in the treatment of patients with heart failure.
Hennekens CH; Kowalczykowski M; Hollar D
J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):149-52. PubMed ID: 16891293
[TBL] [Abstract][Full Text] [Related]
16. Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
Jorde UP; Ennezat PV; Lisker J; Suryadevara V; Infeld J; Cukon S; Hammer A; Sonnenblick EH; Le Jemtel TH
Circulation; 2000 Feb; 101(8):844-6. PubMed ID: 10694521
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
Grothusen A; Divchev D; Luchtefeld M; Schieffer B
Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
[TBL] [Abstract][Full Text] [Related]
18. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
Verdecchia P; Angeli F; Cavallini C; Gattobigio R; Gentile G; Staessen JA; Reboldi G
Eur Heart J; 2009 Mar; 30(6):679-88. PubMed ID: 19168534
[TBL] [Abstract][Full Text] [Related]
19. Are angiotensin II receptor antagonists indicated in chronic heart failure?
Komajda M
Heart Fail Monit; 2002; 2(3):85-7. PubMed ID: 12634889
[TBL] [Abstract][Full Text] [Related]
20. [AT1 blockers against heart failure. The charm of polypharmacy].
MMW Fortschr Med; 2003 Sep; 145(38):6. PubMed ID: 14603670
[No Abstract] [Full Text] [Related]
[Next] [New Search]
